Madison Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Madison Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$28.51 - $32.9 $3.41 Million - $3.94 Million	-119,780 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$26.37 - $34.22 $23,706 - $30,763	899 Added 0.76%	119,780 $3.49 Million
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $10,804 - $14,408	459 Added 0.39%	118,881 $3.17 Million
Q2 2021 Aug 09, 2021	SELL	$26.72 - $33.19 $4,916 - $6,106	-184 Reduced 0.16%	118,422 $3.65 Million
Q1 2021 May 11, 2021	BUY	$24.15 - $31.45 $2.86 Million - $3.73 Million	118,606 New	118,606 $3.11 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Madison Asset Management, LLC with notifications on news.